This regulation represents a negative feedback mechanism, whereby upon recognizing and responding to a pathogen, T cells activate the production of IFN-γ, which, in turn, induces the expression of PD-L1 in target cells, including immune and tumor cells. The gene discussed is IFNG; the disease is neoplasm.